WRBY insider Neil Blumenthal reports 10b5-1 sales

WRBY reporting person Neil Blumenthal disclosed sales of Common Stock effected under a 10b5-1 plan.

Rhea-AI Filing Summary

WRBY reporting person Neil Blumenthal disclosed sales of Common Stock effected under a 10b5-1 plan. The filing lists multiple dispositions, including 36,300 shares on 06/29/2026 for $1,090,564.53 and 63,040 shares on 05/19/2026 for $1,893,236.19.

The entries show the trade dates, share counts, and aggregate proceeds for each listed sale; these reflect dispositions executed under the scheduled plan.

Insights

Securities Attorney

10b5-1 sales documented with dates, share counts, and proceeds; routine disclosure.

The filing lists several scheduled dispositions by Neil Blumenthal under a 10b5-1 plan with explicit trade dates, share quantities, and aggregate proceeds for each sale. The entries include 06/29/2026: 36,300 shares and 05/19/2026: 63,040 shares.

These records are disclosure of executed transactions; cash‑flow recipients and broader holdings are not stated in the excerpt. Subsequent filings may provide additional position context.

Corporate Governance Analyst

Insider used a prearranged trading plan; the pattern is administrative, not a corporate action.

The entries are labeled as 10b5-1 Sales, indicating prearranged dispositions. Each row shows date, share count, and proceeds, for example 04/17/2026: 75,213 shares for $1,847,748.44.

This filing reports the mechanics of executed sales; it does not state any change in ownership limits or company authorization in the provided excerpt.

Key Figures

Sale on 06/29/2026: 36,300 shares Proceeds on 06/29/2026: $1,090,564.53 Sale on 05/19/2026: 63,040 shares +5 more

8 metrics

Sale on 06/29/2026 36,300 shares 06/29/2026 trade listed with proceeds

Proceeds on 06/29/2026 $1,090,564.53 Aggregate proceeds reported for 36,300 shares

Sale on 05/19/2026 63,040 shares 05/19/2026 trade listed with proceeds

Proceeds on 05/19/2026 $1,893,236.19 Aggregate proceeds reported for 63,040 shares

Sale on 04/17/2026 75,213 shares 04/17/2026 trade listed with proceeds

Proceeds on 04/17/2026 $1,847,748.44 Aggregate proceeds reported for 75,213 shares

Sale on 04/20/2026 22,442 shares 04/20/2026 trade listed with proceeds

Proceeds on 04/20/2026 $562,957.57 Aggregate proceeds reported for 22,442 shares

Key Terms

10b5-1, Form 144, Aggregate proceeds

3 terms

10b5-1 regulatory

"10b5-1 Sales for NEIL BLUMENTHAL"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Aggregate proceeds financial

"36300 | 1090564.53"

FAQ

What did the WRBY filing disclose about Neil Blumenthal's transactions?

It discloses multiple 10b5-1 sales of Common Stock with specific dates and amounts. The filing lists trade dates, share counts, and aggregate proceeds for each sale, for example 36,300 shares on 06/29/2026 for $1,090,564.53.

Which sales by Neil Blumenthal are listed in the WRBY excerpt?

The excerpt lists several transactions, including 06/29/2026: 36,300 shares and 05/19/2026: 63,040 shares. Each row pairs a trade date with the number of shares and aggregate proceeds.

Were the sales in the WRBY filing executed under a trading plan?

Yes. The entries are labeled as 10b5-1 Sales, indicating they were executed under a prearranged Rule 10b5-1 plan. The filing enumerates dates, share counts, and proceeds for those plan trades.

Does the filing state who received the sale proceeds?

The excerpt provides aggregate proceeds per trade but does not specify who received the proceeds. Each listed sale shows an amount, for example $1,893,236.19 for 63,040 shares on 05/19/2026.

Does this filing disclose Neil Blumenthal's remaining holdings after these sales?

No. The provided excerpt lists executed sales with dates, counts, and proceeds but does not state post‑transaction holdings or total beneficial ownership as of any date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883345
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Warby Parker Inc.
SEC File Number	001-40825
Address of Issuer	233 Spring Street, 6th Floor East New York NEW YORK 10013
Phone	6468477215
Name of Person for Whose Account the Securities are To Be Sold	NEIL BLUMENTHAL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	217667	6604016.78	107094174	07/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/28/2017	Founder Shares & Previously Exercised Options	Issuer			217667	06/28/2017	N/A & Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	06/29/2026	36300	1090564.53
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	05/19/2026	63040	1893236.19
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/20/2026	22442	562957.57
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/17/2026	75213	1847748.44
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/16/2026	2345	56466.66

144: Remarks and Signature

Remarks	The securities to be sold were acquired from founder shares and previously exercised options during the period of 06/28/2017 through 12/31/2023.
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Neil Blumenthal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)